Expressing effects of osteoporosis interventions in terms of postponing of fractures

European Journal of Clinical Pharmacology

Volumn 58, Issue 9, 2002, Pages 629-633

  Christensen, Palle Mark ^a   Brøsen, Kim ^a   Brixen, Kim ^b   Kristiansen, Ivar Sønbø ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Hip fractures; Markov model; Osteoporosis; Prevention; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MODEL; MORBIDITY; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; RISK; SURVIVAL; BIOLOGICAL MODEL; COHORT ANALYSIS; MALE; MIDDLE AGED; PROBABILITY; RISK FACTOR; SEX DIFFERENCE; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HIP FRACTURES; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOPOROSIS; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 0036460026     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0526-6     Document Type: Article

References (18)

1. Favus (1999) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Lippincott, Williams & Wilkins, Philadelphia
2. Jaeschke R, Guyatt G, Shannon H, Walter S, Cook D, Heddle N (1995) Basic statistics for clinicians: 3. Assessing the effects of treatment: Measures of association. CMAJ 152:351-357
3. Bucher HC, Weinbacher M, Gyr K (1994) Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 309:761-764
4. Fahey T, Griffiths S, Peters TJ (1995) Evidence based purchasing: Understanding results of clinical trials and systematic reviews. BMJ 311:1056-1059
5. Hux JE, Naylor CD (1995) Communicating the benefits of chronic preventive therapy: Does the format of efficacy data determine patients' acceptance of treatment? Med Decis Making 15:152-157
6. Nexoe J, Gyrd-Hansen D, Kragstrup J, Kristiansen IS, Nielsen JB (2002) Danish GPs' perception of disease risk and benefit of prevention. Fam Pract 19:3-6
7. Wright JC, Weinstein MC (1998) Gains in life expectancy from medical interventions - Standardizing data on outcomes. N Engl J Med 339:380-386
8. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: A practical guide. Med Decis Making 13:322-338
9. Lofthus CM, Osnes EK, Falch JA, Kaastad TS, Kristiansen IS, Nordsletten L, Stensvold I, Meyer HE (2001) Epidemiology of hip fractures in Oslo, Norway. Bone 29:413-418
10. Poulsen TK, Ovesen O, Röck ND, Andersen-Ranber F, Møller-Larsen F, Riis J (2001) Hip fractures in the county of Funen, Denmark. Incidences from 1973 to 1978 compared with 1997 and 1998 (abstract). 5th Congress of the European Federation of National Association of Orthopaedics and Traumatology, Rhodes-Greece, 3-7 June P137
11. Eiskjaer S, Ostgard SE, Jakobsen BW, Jensen J, Lucht U (1992) Years of potential life lost after hip fracture among postmenopausal women. Acta Orthop Scand 63:293-296
12. Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ (1998) How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int 8:247-254
13. Browner WS, Seeley DG, Vogt TM, Cummings SR (1991) Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 338:355-358
14. Browner WS, Pressman AR, Nevitt MC, Cummings SR (1996) Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156:1521-1525
15. Chrischilles EA, Butler CD, Davis CS, Wallace RB (1991) A model of lifetime osteoporosis impact. Arch Intern Med 151:2026-2032
16. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535-1541
17. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333-340
18. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642